Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)

117.08 +2.92 (+2.55%)

Streaming Delayed Price Updated: 1:45 PM EDT, Jul 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	242,204
Open	114.15
Bid (Size)	116.54 (500)
Ask (Size)	117.19 (100)
Prev. Close	114.16
Today's Range	113.35 - 117.08
52wk Range	36.65 - 130.05
Shares Outstanding	55,307,775
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Kymera Therapeutics Stock Popped This Week ↗

June 26, 2026

It's getting quite the head start on an important clinical trial.

Via The Motley Fool

These stocks are gapping in today's session ↗

June 25, 2026

Via Chartmill

Performance

YTD	+60.9%	+60.9%
1 Month	+58.3%	+58.3%
3 Month	+34.4%	+34.4%
6 Month	+52.7%	+52.7%
1 Year	+169.6%	+169.6%

More News

Kymera Therapeutics Stays on Track With KT-621 Trials, Teases IRF5 Data ↗

May 26, 2026

Via MarketBeat

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗

May 17, 2026

Via The Motley Fool

Kymera Therapeutics (NASDAQ:KYMR) Soars on Q1 2026 Revenue and EPS Beat ↗

April 30, 2026

Via Chartmill

Kymera Therapeutics Inc (NASDAQ:KYMR) Stock Falls 6.6% After Q4 2025 Earnings Miss and Extended Clinical Timelines ↗

February 26, 2026

Via Chartmill

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗

May 17, 2026

Via The Motley Fool

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗

May 17, 2026

Via The Motley Fool

What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗

May 14, 2026

Via The Motley Fool

This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO ↗

May 14, 2026

Via The Motley Fool

Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗

May 14, 2026

Via The Motley Fool

Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗

March 19, 2026

Via The Motley Fool

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗

March 09, 2026

Via The Motley Fool

Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗

March 06, 2026

Via The Motley Fool

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

Via The Motley Fool

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗

March 04, 2026

Via The Motley Fool

Kymera (KYMR) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗

February 25, 2026

Via The Motley Fool

Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗

February 25, 2026

Via The Motley Fool

Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗

February 25, 2026

Via The Motley Fool

Kymera Stock Up 130% as $135 Million Buy Boosts Immunology Bet ↗

February 23, 2026

Via The Motley Fool

Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗

February 17, 2026

Via The Motley Fool

Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks ↗

January 01, 2026

Via MarketBeat

Streaming Wars Go Hostile Just as Wall Street Braces for the Fed ↗

December 09, 2025

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

December 08, 2025

Via Chartmill

Frequently Asked Questions

Is Kymera Therapeutics, Inc. - Common Stock publicly traded?

Yes, Kymera Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Kymera Therapeutics, Inc. - Common Stock trade on?

Kymera Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Kymera Therapeutics, Inc. - Common Stock?

The ticker symbol for Kymera Therapeutics, Inc. - Common Stock is KYMR on the Nasdaq Stock Market

What is the current price of Kymera Therapeutics, Inc. - Common Stock?

The current price of Kymera Therapeutics, Inc. - Common Stock is 117.08

When was Kymera Therapeutics, Inc. - Common Stock last traded?

The last trade of Kymera Therapeutics, Inc. - Common Stock was at 07/09/26 01:45 PM ET

What is the market capitalization of Kymera Therapeutics, Inc. - Common Stock?

The market capitalization of Kymera Therapeutics, Inc. - Common Stock is 6.48B

How many shares of Kymera Therapeutics, Inc. - Common Stock are outstanding?

Kymera Therapeutics, Inc. - Common Stock has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.